Bill Snyder

Nancy J. Cox, Ph.D., professor of Medicine and Human Genetics and chief of the Section of Genetic Medicine at the University of Chicago, has been appointed founding director of a new genetics institute at Vanderbilt University, effective Jan. 1, 2015. Read More

A nationwide research group headed by Vanderbilt University’s David Robertson, M.D., has received another round of funding from the federal government to continue studies of rare neurodegenerative diseases and disorders affecting blood pressure. Read More

Vanderbilt’s biobank, BioVU, has begun to collect and store plasma, the liquid part of blood, to aid studies of diseases ranging from heart failure and hypertension to breast cancer. Read More

Vanderbilt University is part of a national effort to improve diabetes treatment by developing strategies for proliferating, regenerating and improving the function of insulin-producing beta cells in the pancreatic islets. Read More

Two seniors in the School for Science and Math at Vanderbilt (SSMV) are semifinalists in the 2014 Siemens Competition in Math, Science and Technology for U.S. high school students, and one of them, Zaixing “Able” Shi, is Tennessee’s only regional finalist. Read More

  George Q. Daley, M.D., Ph.D. George Q. Daley, M.D., Ph.D., a pioneer in cellular “engineering” at Boston Children’s Hospital and Harvard Medical School, will deliver the next Flexner Discovery Lecture on Thursday, Oct. 30. Daley’s talk, entitled “CellNet: Enhancing Cellular Engineering through… Read More

Michael Longaker, M.D., director of the Stanford Program in Regenerative Medicine and the Children’s Surgical Research Program, described methods for minimizing scarring through tissue repair and engineering at his recent Flexner Discovery Lecture. (Photo by Anne Rayner)… Read More

New insights to the workings of a protein that moves neurotransmitters across the nerve cell membrane could aid the design of more effective antidepressants. Read More

The transgenic mouse, into which was inserted a rare human genetic variation in the dopamine transporter, could lead to improvements in the diagnosis and treatment of these all-too-common brain disorders. Read More

  Nancy Brown, M.D. Vanderbilt University’s Nancy J. Brown, M.D., chair and physician-in-chief of the Department of Medicine, and James E. Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, are among 70 new members elected to the Institute of Medicine (IOM), the organization… Read More

The Vanderbilt Comprehensive Care Clinic has received a nearly $54,000 grant for 2014-2015 from the Baptist Healing Trust (BHT) for its Pharmacy Support Program, which provides free or low-cost medications to people with HIV/AIDS. Read More

Vanderbilt University researchers are closer to understanding the link between obesity, chronic inflammation and type 2 diabetes. Read More

Vanderbilt University biophysicist Gregor Neuert, Ph.D., M.Eng., is among 50 recipients of the 2014 National Institutes of Health (NIH) Director’s New Innovator Award. Each award provides up to $1.5 million in direct research support over five years. Read More

Michael Longaker, M.D., well known for his contributions to tissue repair and engineering and stem cell biology at Stanford University School of Medicine, will deliver the next Flexner Discovery Lecture on Thursday, Oct. 16. Read More

A Vanderbilt University-led research team has discovered a “master regulator” for cholesterol production and transport in the liver — a tiny piece of RNA called microRNA-223. Read More

Vanderbilt University has launched a regenerative visual neuroscience initiative to develop new ways of treating — and restoring sight to — people who have been blinded by glaucoma, macular degeneration, diabetic retinopathy and eye injuries. Read More

Jeff Balser, M.D., Ph.D., delivers Tuesday’s State of the Medical Center Address in Langford Auditorium. (photo by Joe Howell) He began with a simple thank you. That’s how Jeff Balser, M.D., Ph.D., Vanderbilt’s vice chancellor for Health Affairs and dean of the School of Medicine chose to… Read More

Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee. Read More

Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee. Read More

Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses. Read More